DiaSorin Molecular Pneumocystis Jirovecii Primer Pair
DiaSorin Molecular has introduced a Pneumocystis jirovecii primer pair for use in laboratory-developed molecular tests. This analyte-specific reagent can be used for the amplification and detection of the P. jirovecii mtLSU gene with a CFR610- and BHQ-2-labeled probe and forward and reverse primers. This is DiaSorin's first fungal infectious disease target, and the new primer pair adds to the company's menu of more than 60 molecular reagents for the detection of bacterial and viral targets, and human genetic mutations.
Interpace Diagnostics MVPdX Lung Cancer Test
Interpace Diagnostics has launched a new lung cancer test, MVPdX, that compares the mutational fingerprint of two or more sites of lung cancer to differentiate new primary lung tumors from recurrences or metastases. The assay is based on an analysis of loss of heterozygosity via a panel of microsatellite markers in proximity to 16 tumor suppressor genes.
Lexogen SLAM-seq Kits
Lexogen has launched its SLAM-seq line of products for metabolic RNA sequencing. The kits are based on technology developed at the Institute of Molecular Biotechnology in Vienna, Austria, that involves labeling metabolic RNA. The technology, thiol-linked alkylation for the metabolic sequencing of RNA, was described this week in a study published in Nature Methods. The SLAM-seq kit can be combined with Lexogen's QuantSeq 3' mRNA kit for library prep.
For more new products and services, please visit the New Products page on our website.